BioLife Solutions Inc.
BLFS | NASDAQ
$38.02
+$0.84 (+2.26%)
Sep 22, 2026, 2:43 PM ET · Market open
Market Data
Market Cap $1.82B
Enterprise Value $1.75B
Beta 1.92
Average Volume 965.73K
Shares Outstanding (Diluted) 49.29M
Shares Change YoY 3.13%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US09062W2044
Price Performance
Price Change 1M -0.1%
Price Change 3M 50.0%
Price Change 6M 87.2%
Price Change YTD 55.6%
Price Change 1Y 47.1%
Price Change 3Y 182.7%
Price Change 5Y -20.8%
1M CAGR (ann.) 7.3%
1Y CAGR (ann.) 41.5%
5Y CAGR (ann.) -6.4%
All-Time CAGR 18.5%
Valuation
PE Ratio 36.45
Forward PE 119.69
PEG Ratio -0.01
Forward PEG -0.75
PS Ratio 17.67
Forward PS 13.50
PB Ratio 4.33
P/FCF Ratio -655.31
P/Adj. FCF Ratio -62.17
P/OCF Ratio 106.23
EV/Sales 17.02
EV/EBIT 282.00
EV/EBITDA 178.88
EV/FCF -631.26
Earnings Yield 2.7%
FCF Yield -0.1%
Adj. FCF Yield -1.6%
Financial Health
Net Cash $79.82M
Total Debt $15.74M
Cash & Short-Term Investments $82.42M
Total Assets $447.49M
Current Ratio 9.69
Quick Ratio 7.14
Debt / Equity Ratio 0.04
Debt / EBITDA 1.61
Debt / FCF -5.68
OCF / Debt 1.04
Interest Coverage 11.29
Altman Z-Score 39.33
Piotroski F-Score 5
Margins & Profitability
Gross Profit Margin 64.5%
Operating Profit Margin 7.3%
EBITDA Margin 9.5%
Net Profit Margin 49.1%
FCF Margin -2.7%
Adj. FCF Margin -28.4%
SBC / Revenue 12.6%
SBC Impact (per share) -954.1%
Returns
Return on Assets 11.3%
Return on Equity 13.3%
Return on Invested Capital 1.7%
Return on Capital Employed 1.7%
Return on Tangible Assets 21.4%
Historical Growth (CAGR)
Revenue CAGR 3Y -14.1%
Revenue CAGR 5Y 6.8%
Revenue CAGR 10Y 30.3%
EPS CAGR 3Y 539.2%
EPS CAGR 5Y 83.2%
EPS CAGR 10Y -1.2%
FCF CAGR 3Y 35.9%
FCF CAGR 5Y 105.7%
FCF CAGR 10Y -3.7%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 18
EPS Growth Next 3Y 7.8%
Revenue Growth Next 3Y 24.8%
Earnings Date Nov 4, 2026
EPS Estimate (next Q) $0.01
EPS Growth Est (next Q) -75.0%
Revenue Est (next Q) $29.17M
Revenue Growth Est (next Q) 3.8%
Fair Value Estimates
Graham Number $14.04
Graham Upside -62.2%
Lynch Fair Value $25.50
Lynch Upside -31.4%
Price Target $31
Price Target Upside -16.6%
Cash Flow
Operating Cash Flow $16.39M
Free Cash Flow $-2.77M
Adj. Free Cash Flow $-29.22M
FCF Per Share -$0.02
OCF Per Share $0.35
OCF/S Ratio 16.4%
Income Statement
Revenue $102.82M
Gross Profit $65.6M
Operating Income $7.45M
EBITDA $9.78M
Net Income $50.45M
EPS (Diluted) $1.02
Revenue / Employee $663.34K
Profit / Employee $325.46K
Employees 155
Add to Watchlist
Select watchlists to add or remove BLFS